Can urologists introduce the concept of "oligometastasis" for metastatic bladder cancer after total cystectomy?

about

Can urologists introduce the concept of "oligometastasis" for metastatic bladder cancer after total cystectomy?

Item

http://www.wikidata.org/entity/Q49235556

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Can urologists introduce the c ...... cancer after total cystectomy?

@en

Can urologists introduce the c ...... cancer after total cystectomy?

@nl

type

Item

label

Can urologists introduce the c ...... cancer after total cystectomy?

@en

Can urologists introduce the c ...... cancer after total cystectomy?

@nl

prefLabel

Can urologists introduce the c ...... cancer after total cystectomy?

@en

Can urologists introduce the c ...... cancer after total cystectomy?

@nl

P1476

Can urologists introduce the c ...... cancer after total cystectomy?

@en

P2093

Kazuhiro Matsumoto

http://www.w3.org/2001/XMLSchema#string

Keitaro Watanabe

http://www.w3.org/2001/XMLSchema#string

Kimiharu Takamatsu

http://www.w3.org/2001/XMLSchema#string

Koichiro Ogihara

http://www.w3.org/2001/XMLSchema#string

Masafumi Oyama

http://www.w3.org/2001/XMLSchema#string

Mototsugu Oya

http://www.w3.org/2001/XMLSchema#string

Ryohei Kufukihara

http://www.w3.org/2001/XMLSchema#string

Satoshi Hara

http://www.w3.org/2001/XMLSchema#string

Shintaro Hasegawa

http://www.w3.org/2001/XMLSchema#string

Takeshi Masuda

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA expression characterizes oligometastasis(es)

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

MicroRNA‑328 directly targets p21‑activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

Micro-RNAs as Potential Predictors of Response to Breast Cancer Systemic Therapy: Future Clinical Implications.

International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

The biology and treatment of oligometastatic cancer.

Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation.

Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.

Adverse event reporting in cancer clinical trial publications.

P304

111819-111835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22911

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eiji Kikuchi

P577

2017-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29340094

http://www.w3.org/2001/XMLSchema#string

P932

5762362

http://www.w3.org/2001/XMLSchema#string